Clinical Trials Directory

Trials / Conditions / Unresectable Soft Tissue Sarcoma

Unresectable Soft Tissue Sarcoma

9 registered clinical trials studyying Unresectable Soft Tissue Sarcoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingFirst-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
NCT06797999
Adcendo ApSPhase 1 / Phase 2
WithdrawnGemcitabine With Ascorbate Including Adolescents
NCT04877587
David DickensEARLY_Phase 1
Active Not RecruitingGemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
NCT04634227
University of IowaEARLY_Phase 1
Active Not RecruitingCabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tis
NCT04200443
City of Hope Medical CenterPhase 2
TerminatedGemcitabine Plus Ascorbate for Sarcoma in Adults
NCT03468075
Mohammed Milhem, MBBSPhase 2
WithdrawnImmune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
NCT03397186
Fred Hutchinson Cancer CenterPhase 2
CompletedRibociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B
NCT03009201
OHSU Knight Cancer InstitutePhase 1
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Su
NCT02500797
National Cancer Institute (NCI)Phase 2
CompletedPreliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
NCT01514188
ImmunityBio, Inc.Phase 2